An increase in regulatory cytokine IL-2 and TGF-β was detected, as was the reduction of IL-4, IL-17, and IL-1β, reflecting the cancer patient's immunosuppressive environment and the lower prevalence of allergies. The gene discussed is IL17A; the disease is allergic disease.